Sun Pharma Advanced Research Company Limited Share Price
Equities
SPARC
INE232I01014
Pharmaceuticals
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 139.86 INR | -8.55% |
|
+4.00% | -30.41% |
| Capitalization | 4.96TCr 55Cr 47Cr 44Cr 41Cr 76Cr 83Cr 519.43Cr 200.56Cr 2.34TCr 206.98Cr 202.56Cr 8.57TCr | P/E ratio 2024 |
-30.9x | P/E ratio 2025 | -14x |
|---|---|---|---|---|---|
| Enterprise value | 5.23TCr 58Cr 50Cr 47Cr 44Cr 81Cr 88Cr 547.37Cr 211.35Cr 2.47TCr 218.11Cr 213.46Cr 9.03TCr | EV / Sales 2024 |
157x | EV / Sales 2025 | 70.6x |
| Free-Float |
25.1% | Yield 2024 * |
-
| Yield 2025 | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Sun Pharma Advanced Research Company Limited
More press releases
| 1 day | -8.75% | ||
| 1 week | +4.00% | ||
| Current month | +3.75% | ||
| 1 month | +6.23% | ||
| 3 months | -1.08% | ||
| 6 months | -16.35% | ||
| Current year | -30.41% |
| 1 week | 134.19 |  | 179.43 |
| 1 month | 128.11 | | 179.43 |
| Current year | 109.3 | | 208.3 |
| 1 year | 109.3 | | 241 |
| 3 years | 109.3 | | 472.8 |
| 5 years | 109.3 | | 472.8 |
| 10 years | 81 | | 532 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 55 | 24/04/2014 | |
| Chief Operating Officer | - | 26/07/2024 | |
| Compliance Officer | - | 22/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 09/11/2009 | |
| Director/Board Member | 64 | 04/06/2007 | |
Robert Spiegel
BRD | Director/Board Member | 73 | 01/06/2020 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0% | 51 M€ | +4.72% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -8.55% | +4.00% | -35.93% | -42.04% | 55Cr | |
| -0.41% | -6.06% | +22.21% | +171.61% | 90TCr | |
| -0.27% | -2.41% | +35.24% | +13.98% | 49TCr | |
| -1.15% | -0.71% | +28.32% | +36.69% | 40TCr | |
| +1.22% | +1.81% | +22.32% | +3.85% | 33TCr | |
| +0.76% | -1.43% | +27.43% | +20.52% | 28TCr | |
| +0.30% | +2.82% | +19.94% | +25.67% | 26TCr | |
| -1.16% | -4.87% | -3.27% | -9.42% | 25TCr | |
| -1.76% | -2.88% | -60.96% | -31.93% | 21TCr | |
| -3.02% | -4.51% | +21.03% | +15.44% | 18TCr | |
| Average | -1.42% | -0.63% | +7.63% | +20.44% | 32.97TCr | |
| Weighted average by Cap. | -0.45% | -2.79% | +17.76% | +55.76% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 76Cr 83.94L 72.16L 67.59L 63L 1.16Cr 1.27Cr 7.91Cr 3.05Cr 36Cr 3.15Cr 3.08Cr 130.46Cr | 72Cr 79.74L 68.55L 64.21L 59.85L 1.11Cr 1.2Cr 7.51Cr 2.9Cr 34Cr 2.99Cr 2.93Cr 123.93Cr |
| Net income | -387.21Cr -4.3Cr -3.7Cr -3.46Cr -3.23Cr -5.96Cr -6.49Cr -41Cr -16Cr -182.88Cr -16Cr -16Cr -668.67Cr | -342.51Cr -3.81Cr -3.27Cr -3.06Cr -2.86Cr -5.28Cr -5.74Cr -36Cr -14Cr -161.76Cr -14Cr -14Cr -591.47Cr |
| Net Debt | -96Cr -1.07Cr -91.67L -85.88L -80.04L -1.48Cr -1.61Cr -10Cr -3.88Cr -45Cr -4Cr -3.92Cr -165.75Cr | 266.97Cr 2.97Cr 2.55Cr 2.39Cr 2.23Cr 4.11Cr 4.47Cr 28Cr 11Cr 126.09Cr 11Cr 11Cr 461.03Cr |
More financial data
* Estimated data
Employees
316
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/25/08 | 139.86 ₹ | -8.55% | 63,69,828 |
| 05/25/05 | 152.94 ₹ | +0.55% | 1,59,56,510 |
| 04/25/04 | 152.10 ₹ | +0.36% | 6,23,46,930 |
| 03/25/03 | 151.55 ₹ | -5.88% | 12,17,16,500 |
| 02/25/02 | 161.02 ₹ | +19.99% | 2,61,32,950 |
Delayed Quote NSE India S.E., December 08, 2025 at 03:06 pm IST
More quotes
Net sales - Rate of surprise
- Stock Market
- Equities
- SPARC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition